BCIQ Profiles

Company Profile Report

Syros, SteadyMed complete private placements

Cancer company Syros Pharmaceuticals Inc. (NASDAQ:SYRS) and drug delivery play SteadyMed Ltd. (NASDAQ:STDY) raised a total of $65 million in private placements on

Read the full 234 word article

How to gain access

Continue reading with a
two-week free trial.